Deadline: 29 December 2024
SPARTNERS incubator is calling for HUMAN HEALTH & BIOTECH STARTUPS looking for equipped labs, advanced infrastructure, expert support, and a collaborative environment to accelerate their innovation!
Coming from a partnership between Servier and BioLabs, Spartners is a cutting-edge incubator embedded in Servier’s new R&D center in Paris-Saclay, managed by BioLabs’ scientist staff and designed to empower biotech startups addressing unmet medical needs.
With access to fully equipped state-of-the-art labs, modular workspaces, and a collaborative ecosystem, startups can thrive in a space dedicated to innovation and interaction.
Driven by BioLabs’ operational excellence and enhanced by Servier’s scientific expertise, Spartners offers unparalleled opportunities for entrepreneurs to test, develop, and grow their ideas in a world-class R&D environment.
Priority Areas
- Priority areas of Servier are Oncology, Neurology and Drug discovery platforms.
Benefits
- State-of-the-art Infrastructure
- The site offers over 110 lab benches splitted between shared open lab spaces, premium private labs as well as open space or private offices for business resources.
- Expert’s Support
- Supported by a staff of scientists, you will also benefit from Servier’s expertise and an opening to its experimental platforms at no charge, as well as animal facilities.
- Strategic Networking Hub
- Located in the innovation hub of Paris-Saclay, Spartners offers unparalleled opportunities to connect with leading researchers, academic institutes, industry experts, and fellow entrepreneurs.
Why should you apply now?
- Limited spots available – Don’t miss your chance to secure access to top-tier labs and a global network to drive your success.
- Program offering an unmatched value – Combining top-tier resources and expertise with the most competitive price point.
Eligibility Criteria
- HUMAN HEALTH & BIOTECH STARTUPS looking for equipped labs, advanced infrastructure, expert support, and a collaborative environment to accelerate their innovation!
For more information, visit Hello Tomorrow.